TERRANOVA, CORRADO
 Distribuzione geografica
Continente #
AS - Asia 7.008
NA - Nord America 2.564
EU - Europa 954
SA - Sud America 347
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 48
OC - Oceania 7
Totale 10.979
Nazione #
SG - Singapore 5.484
US - Stati Uniti d'America 2.424
CN - Cina 692
IT - Italia 477
HK - Hong Kong 400
BR - Brasile 253
VN - Vietnam 131
GB - Regno Unito 120
FR - Francia 113
BD - Bangladesh 104
DE - Germania 78
CA - Canada 70
IN - India 61
MX - Messico 42
AR - Argentina 41
NL - Olanda 27
JP - Giappone 19
CZ - Repubblica Ceca 18
TR - Turchia 17
IQ - Iraq 16
ZA - Sudafrica 16
ID - Indonesia 15
MD - Moldavia 13
RU - Federazione Russa 13
EC - Ecuador 12
FI - Finlandia 11
CL - Cile 10
EE - Estonia 9
ES - Italia 9
PL - Polonia 9
CO - Colombia 8
PH - Filippine 8
SA - Arabia Saudita 8
UA - Ucraina 8
AT - Austria 7
MY - Malesia 7
PK - Pakistan 7
SE - Svezia 7
AU - Australia 6
EG - Egitto 6
VE - Venezuela 6
JM - Giamaica 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
TW - Taiwan 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
KR - Corea 4
NP - Nepal 4
RS - Serbia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
CH - Svizzera 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
PR - Porto Rico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
LT - Lituania 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CU - Cuba 1
ET - Etiopia 1
GD - Grenada 1
GN - Guinea 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LR - Liberia 1
ML - Mali 1
NI - Nicaragua 1
Totale 10.921
Città #
San Jose 679
Ashburn 527
Singapore 518
Hong Kong 391
Rome 317
Hefei 212
Beijing 172
Council Bluffs 131
Santa Clara 119
Boardman 118
Columbus 109
Lauterbourg 89
London 89
Shanghai 71
New York 49
Ho Chi Minh City 45
Los Angeles 44
San Francisco 35
Munich 34
Dallas 31
São Paulo 30
Buffalo 27
Montreal 24
Washington 23
Hanoi 22
Mexico City 22
Toronto 21
Brno 18
Milan 17
Amsterdam 16
Tokyo 16
Seattle 15
Chicago 13
Naples 13
Rio de Janeiro 13
Secaucus 13
Brooklyn 11
Johannesburg 11
Pune 11
Las Vegas 10
Da Nang 9
Grumo Nevano 9
Paris 9
Boston 8
Phoenix 8
Sorab 8
Warsaw 8
Coral Springs 6
Frankfurt am Main 6
Haiphong 6
Helsinki 6
Orem 6
Santiago 6
The Dalles 6
Baghdad 5
Catania 5
Duque de Caxias 5
Guangzhou 5
Guayaquil 5
Medellín 5
Stockholm 5
Temecula 5
Thái Bình 5
Ankara 4
Biên Hòa 4
Buenos Aires 4
Campinas 4
Canberra 4
Cape Town 4
Cuautitlán Izcalli 4
Dhaka 4
Guarulhos 4
Hyderabad 4
Kuala Lumpur 4
Lahore 4
Louisville 4
New Delhi 4
Newark 4
Ninh Bình 4
Nuremberg 4
Ribeirão Preto 4
Riyadh 4
Salt Lake City 4
Taipei 4
Turku 4
Alexandria 3
Anápolis 3
Asunción 3
Bologna 3
Brasília 3
Caracas 3
Charlotte 3
Cincinnati 3
Cleveland 3
Cusano Milanino 3
Dalian 3
Florence 3
Hải Dương 3
Jakarta 3
Karbala 3
Totale 4.405
Nome #
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 274
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 267
A comparison of three different entry techniques in gynecological laparoscopic surgery: a randomized prospective trial 255
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 251
The challenge of preoperative identification of uterine myomas: Is ultrasound trustworthy? A prospective cohort study 246
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 246
Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies 244
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 235
Analysis of ultrasonographic and hystopathologic features of placental invasiveness in Vitro Fertilization (IVF) pregnancies: a prospective study 231
Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment 228
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 225
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 224
Human embryo: what about relatedness? 218
Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study 217
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 214
Intraoperative contact ultrasonography during open myomectomy for uterine fibroids 212
Chronic subtorsion of the ovary with subsequent ovarian hypoplasia 211
Does HE4 have a role in the recurrence of ovarian cancer? 210
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 202
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 201
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 194
A critical review on HE4 performance in endometrial cancer: where are we now? 151
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 146
A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection 146
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 142
[The role of laparoscopy in ovarian carcinoma]. 137
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 130
A new type of absorbable barbed suture for use in laparoscopic myomectomy 126
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 124
Assessing HPV vaccination perceptions with online social media in Italy 122
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 122
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 119
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 119
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 117
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 115
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 114
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 113
Economic impact among family caregivers of patients with advanced ovarian cancer 113
Feasibility and safety of carboplatin plus paclitaxel as neoadjuvant chemotherapy for locally advanced cervical cancer: a pilot study 110
Chirurgia Benigna 108
The Rendezvous Technique: A Minimally Invasive Non-Surgical Approach for the Management of Iatrogenic Ureteral Injuries 106
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 104
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 88
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 87
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 83
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 82
The endogenous oxytocin after manipulative osteopathic treatment in full-term pregnant women 81
The role of ovarian fossa evaluation in patients with ovarian endometriosis 74
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 73
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 73
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 70
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 69
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 68
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study 67
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 66
Miomectomia laparoscopica: fattibilità e learning curve 66
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 62
Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers 62
Laparoscopic myomectomy learning curve safety and feasibility. 62
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 61
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 61
Ovarian cancer relapse: From the latest scientific evidence to the best practice 59
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis. 59
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 59
PREOPERATIVE LOCAL STAGING OF ENDOMETRIAL CANCER: THE CHALLENGE OF IMAGING TECHNIQUES AND SERUM BIOMARKERS 58
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 58
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 57
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix 56
European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis 56
Studio prospettico randomizzato comparativo tra due tecniche 56
Prenatal genetic diagnosis: Fetal therapy as a possible solution to a positive test 55
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 54
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program 54
Continuous wound infusion as a valid alternative to tap block for postoperative analgesia after abdominal hysterectomy: A randomized controlled trial 53
Use of music to reduce anxiety during office hysteroscopy: prospective randomized trial 53
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 52
Preeclampsia and the challenge of early prediction: reality or utopia? State of art and critical review of literature 51
Ten years of HPV vaccines: State of art and controversies 51
Real-time infrared thermography for ureter detection during hysterectomy 51
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 49
Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues 48
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 48
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 48
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 47
NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER 47
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 47
Dual HER2/PIK3CA targeting overcomes single-agent acquired resistance in HER2-amplified uterine serous carcinoma cell lines in vitro and in vivo 46
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 46
The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study 46
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women 46
Studio prospettico randomizzato comparativo tra due tecniche chirurgiche per il trattamento dell’incontinenza urinaria da sforzo: accesso retropubico vs transotturatorio 46
RANDOMIZED CONTROL TRIAL COMPARING FOUR VERSUS SIX COURSES OF ADJUVANT PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED CERVICAL CANCER PREVIOUSLY TREATED WITH NEO-ADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY 46
Hormone replacement therapy in cancer survivors: Utopia? 45
The role of macroplastique implantation in the management of occult urinary stress incontinence 45
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 44
TOTAL RECTOSIGMOIDECTOMY VERSUS PARTIAL RECTAL RESECTION IN ADVANCED OVARIAN CANCER SURGICAL DEBULKING: A CASE CONTROL STUDY 44
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 43
Role of human epididymis protein 4 (HE4) as predictor of response to platinum based chemotherapy: a systematic review of literature 42
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 42
ROBOTIC PELVIC LYMPHADENECTOMY: STEPS AND TECHNIQUE 42
Totale 10.693
Categoria #
all - tutte 57.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022138 0 0 3 1 0 0 1 4 4 3 0 122
2022/202351 0 0 1 2 1 1 12 2 3 3 17 9
2023/2024491 10 42 46 43 43 147 4 64 9 20 30 33
2024/20255.876 107 25 122 33 27 98 83 65 276 341 2.288 2.411
2025/20264.074 313 168 182 399 202 225 1.134 253 376 407 239 176
2026/2027349 74 275 0 0 0 0 0 0 0 0 0 0
Totale 10.979